0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Ribodeoxyviruses and Cancer

Howard M. Temin, PhD
JAMA. 1974;230(7):1043-1045. doi:10.1001/jama.1974.03240070075042.
Text Size: A A A
Published online

Ribodeoxyviruses are viruses whose particles (virions) are enveloped and contain RNA and a DNA polymerase. Some of these viruses cause cancer, but most do not, nor any other disease. Ribodeoxyviruses replicate through a DNA intermediate, the DNA provirus. The DNA provirus can be assayed as infectious DNA.

Because ribodeoxyvirus information can be present in cells as a part of the cell genome, it needs no viral functions for its maintenance. Therefore, ribodeoxyviruses often persist in cells with little or no viral gene expression.

Most cancers in animals do not contain infectious ribodeoxyviruses, although they may contain ribodeoxyvirus genes and products. These same genes and products are, however, found with about the same frequency in normal cells, so that their presence in human tumors would not indicate an etiologic relationship between ribodeoxyviruses and human cancer.

It has been suggested that ribodeoxyviruses and the genes for cancer evolve independently from a normal cellular system of DNA-to-RNA-to-DNA information transfer.

(JAMA 230:1043-1045, 1974)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();